| Literature DB >> 31531049 |
Masoumeh Ghalkhani1, Fatemeh Ghorbani-Bidkorbeh2.
Abstract
Pharmaceutical drugs play an important role in human life since they caused a revolution in human health. Notably, their administration to a living organism helps body to stay healthy. Commonly, they are employed to diagnose, prevent, or treat and cure a disease via a biological effect on a human body. Administration of impurity-free and adequate amounts of pharmaceutical compounds would be beneficial. Therefore, the quantity and purity of the substances in pharmaceutical compounds are continuously monitored during drug manufacturing with various chemical or instrumental analysis techniques. The possibility of impurities development and chemical or quantity changes of active drug species at various stages (namely during production, transportation or storage) makes them redundant and risky for human health. So, sensitive and accurate analysis methods for qualitative and quantitative analysis are highly demanded by pharmaceutical companies and medical centers. The present mini review emphasizes on application of carbon based modified electrodes in health care and pharmaceutical analysis. Electrochemical determination of drugs employing carbon nanostructured modified electrodes will be reviewed and their advantages and disadvantages will be mentioned.Entities:
Keywords: Carbon Nanotube; Carbon nanostructures; Graphene; Modified electrode; Nanoparticle; Pharmaceutical; Voltammetric
Year: 2019 PMID: 31531049 PMCID: PMC6706716 DOI: 10.22037/ijpr.2019.1100645
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Scheme 1Various carbon nanostructured based modified electrodes (CNSs: Carbon nanostructures; SWCNT: Single walled carbon nanotubes; G: Graphene; GQDs: Graphene quantum dots; GO: Graphene oxide; RGO: Reduced graphene oxide; CQDs: Carbon quantum dots; CB: Carbon black; CNPs: Carbon nanoparticles; MWCNTS: Multi walled carbon nanotubes)
Comparison of figures of merit of MWCNTs modified electrodes used in pharmaceutical analysis
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| P-Dopa/ MWCNTs-COOH/GCE | Metronidazole | DPV | 5-5000 | 250 | |
| MWCNT/PMB/AuNP/GCE | Nevirapine | DPASV | 0.1-50 | 53 | |
| MWCNTs/GO/pyrogallol/GCE | Omeprazole | DPV | 0.0002-100 | 0.01 | |
| Functionalized MWCNTs/GCE | MebeverineHydrochloride | SWAdASV | 0.0005-0.035 | 0.13 | |
|
| Raloxifene | DPV | 0.08-400 | 40 | |
| Poly(o-anisidine)/CNTs/GCE | Mebendazole | DPV | 1-35 | 400 | |
| 3DG-CNTN/GCE | Methotrexate | DPV | 0.7-199 | 70 |
Linear range.
Detection limit.
Polydopamine/carboxylic multi-walled carbon nanotubes.
MWCNs/poly(methylene blue)/gold nanoparticle.
Differential pulsed adsorptive striping voltammetry.
Square wave adsorptive anodic striping voltammetry.
1-methyl-3-octylimidazolium tetrafluoroborate/ZnO/CNTs nanocomposite/carbon paste electrode.
3D graphene–carbon nanotube network.
Comparison of figures of merit of CNPs, carbon black and CQDs modified electrodes used in pharmaceutical analysi
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Activated CNPs/CPE | Naproxen | DPV | 0.1-120 | 23.4 | |
| CNPs/SDS/CPE[ | Dopamine | DPV | 0.1-100 | 120 | |
| CNP/GCE | Acetaminophen | DPV | 0.1-100 | 50 | |
| Tramadole | 10-1000 | 500 | |||
| CNP/GCE | Ractopamine | DPV | 2-30 | 0.2 | |
| Nanocellulose/CNP/GCE | Metoclopramide | LSV | 0.06-2 | 6 | |
| Carbon nanofiber/CNP/GCE | Folic acid | DPV | 0.1-10 | - | |
| Melamine/CNPs/GCE | Raloxifene | DPV | 0.4-2 | 10 | |
| TiO2/Nafion/CNP/GCE | Dobutamine | ASDPV | 0.006-1 | 2 | |
| CB/Ag/PEDOT,PSS/GCE | Paracetamol | SWV | 0.62-7.1 | 12 | |
| Levofloxacin | 0.67-12 | 14 | |||
| CB/GCE | Estradiol | Ampreometry | 0.15-3.5 | 92 | |
| CB/GCE | L-cysteine | Chronoamperometry | 50-700 | 45.87 | |
| CB/GCE | Ethinyl Estradiol | DPV | 0.25-3 | 0.13 | |
| CQD/GCE | Dopamine | LSV | 0.19-11.81 | 2.7 | |
| PBG/CQDs/GCE | Guanine | DPV | 0.5-142 | 16 | |
| Adenine | 0.3-130 | 26 | |||
| β-CD/CQD/GCE | Dopamine | DPV | 4-220 | 14 | |
| Tryptophan | 5-270 | 16 |
Linear range.
Detection limit.
Carbon NPs/Sodium dodecyl sulfate/Carbon paste electrode.
Carbon black/Ag NPs/PEDOT:PSS/GCE.
Linear sweep voltammetry.
Poly(bromocresol green)/CQD/GCE.
Poly(β-cyclodextrin)/CQD/GCE.
Comparison of figures of merit of modified electrodes used for dopamine analysis
|
|
|
|
|
|
|---|---|---|---|---|
| GNS-CNTs/MoS2/GCE | DPV | 0.1-100 | 50 | |
| Chitosan-Graphene | DPV | 1-24 | 1000 | |
| Graphene | DPV | 4-100 | 2064 | |
| MWCNT/GONR | AmperometrY | 0.15–12.15 | 80 | |
| GQD/GSPE | DPV | 0.1-1000 | 50 | |
| Eox-SWCNT/PET film electrode | DPV | 1.5-30 | 510 | |
| CB-ERGO/SPCE | SWV | 4.9-19 | 410 |
Linear range.
Detection limit.
Graphene nanosheets-MWCNTs/molybdenum sulfide. flowers/GCE.
Graphene oxide nanoribbons.
Graphene quantum dots graphite screen-printed electrode.
Electrochemically oxidized single-walled CNT/poly(ethylene terephthalate) electrode.
carbon black- electrochemically reduced graphene oxide composite modified screen printed carbon electrodes.
Comparison of figures of merit of GO, RGO and Gr modified electrodes used in pharmaceutical analysis
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| GNS-CNTs/MoS2/GCE[ | Dopamine | DPV | 0.1-100 | 50 | |
| PP3CA/ERGO/GCE | Breast Cancer (BRCA) | DPV | 10 fM–0.1 | 3 fM | |
| AuNP-rGO-CS/GCE | Methylparaben | SWV | 0.03-1.3 | 13.77 | |
| AuNP-rGO/GCE | Hesperidin | Amperometry | 0.05-8 | 8.2 | |
| Graphen/Carbon paste electrode | Promazine | SWV | 0.1-8 | 8 | |
| Gr nanoplatelets-carbon nanofibers/GCE | Nepafenac | AdSSWV | 0.25-15 | 63 | |
| Graphene/TiO2/V2O5/CPE | Chlorpromazine | DPV | 0.033-85 | 5.3 |
Linear range.
Detection limit.
Graphene nanosheets and multiwalled carbon nanotubes.
Poly pyrrole-3-carboxylic acid/electrochemically reduced GO/GCE.
Au NPs/RGO/Chitosan/GCE.
Adsorptive stripping square-wave voltammetry.